Full Press Release Details
to Participate in Two Upcoming Investor Conferences
October 29, 8:00 am ET
Oct. 29 /Xinhua-PRNewswire/ -- Sinovac Biotech Ltd. (Amex: SVA - News), a
vaccine-focused biotech company in China, announced today that it is scheduled
to present at two upcoming investor conferences, including the Oppenheimer 19th
Annual Healthcare Conference in New York City and the Credit Suisse Asian
Healthcare Conference in Beijing, China.
Vanessa Wu, Senior Financial Manager, is scheduled to present on Tuesday,
November 4, 2008 at 3:20 pm at Oppenheimer 19th Annual Healthcare Conference, at
the Waldorf-Astoria Hotel in New York, NY.
Weidong Yin, Chairman, President and CEO, is scheduled to attend the Credit
Suisse Asian Healthcare Conference on November 5 and 6, at The Westin Beijing
Hotel at Financial Street in Beijing, China.
Biotech Ltd. is a China-based biopharmaceutical company that focuses on the
research, development, manufacture and commercialization of vaccines that
protect against human infectious diseases. Sinovac's commercialized vaccines
include Healive (hepatitis A), Bilive (combined hepatitis A and B), Anflu
(influenza) and Panflu(TM) (H5N1). Sinovac is currently developing Universal
Pandemic Influenza vaccine and Japanese encephalitis vaccine. Additional
information about Sinovac is available on its website, http://www.sinovac.com .
To be added to our distribution list, please email:
announcement contains forward-looking statements. These statements are made
under the "safe harbor" provisions of the U.S. Private Securities Litigation
Reform Act of 1995. These forward-looking statements can be identified by words
or phrases such as "will," "expects," "anticipates," "future," "intends,"
"plans," "believes," "estimates" and similar statements. Among other things, the
business outlook and quotations from management in this press release contain
forward-looking statements. Statements that are not historical facts, including
statements about Sinovac's beliefs and expectations, are forward-looking
statements. Forward-looking statements involve inherent risks and uncertainties.
A number of important factors could cause actual results to differ materially
from those contained in any forward- looking statement. Sinovac does not
undertake any obligation to update any forward-looking statement, except as
required under applicable law.
information, please contact:
Tel: +86-10-8289-0088
Fax: +86-10-6296-6910
Tel: +1-646-536-7017
Tel: +1-646-536-7033